Brain imaging study on substance use and depression
Treatments studied
Part of Mental health clinical trials.
This study uses brain scans to understand how substance use and mental illness, like depression, are linked. It may help develop better treatments by looking at brain activity in people with and without depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 60 years old
- Able to provide informed consent
- Not pregnant or breastfeeding
- No alcohol on scan days
- Depending on the study group: either currently depressed, previously depressed, or no depression history
- Daily nicotine users are needed for one part of the study
- Must be English-speaking
- No MRI contraindications (e.g., metal implants, pacemaker)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain imaging (MRI) and tasks to better understand what’s happening in the brain in addiction. It may help researchers improve how addiction is studied and measured using brain-based methods.
This trial looks at how a specific brain receptor related to pain signals (nociceptin/orphanin FQ receptor) may be involved in depression. It may help researchers understand depression better by comparing people with current versus past (remitted) major depression.
This trial uses a special brain scan to see how nicotine might help treat depression. It compares people with depression to healthy volunteers to understand how nicotine affects brain chemistry related to mood.
This study tests a non-invasive brain stimulation treatment (called transcranial magnetic stimulation) for people who have both depression and substance use disorder. The treatment may help reduce depression symptoms and could also help with substance use.
This study looks at how cannabis affects the brain and mood in teens and young adults. It compares people who use cannabis, people with depression who don't use cannabis, and healthy volunteers to understand links between cannabis use and mental health.
This early study tests whether nitrous oxide, aimed at specific brain circuits, can change depression-related brain activity. It is mainly for adults with major depression or treatment-resistant depression, and includes brain imaging during the study.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.